HTT and juvenile Huntington disease: To assess the silencing efficiency and therapeutic potential of G58TF/siRNA-RVG-EVs in the brain, we targeted silencing of the huntingtin gene (Htt) in the Huntington’s disease (HD) mouse model Q14054.